Compounds > 4-n-butylresorcinol

Page last updated: 2024-09-05

4-n-butylresorcinol and Melanosis

4-n-butylresorcinol has been researched along with Melanosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Huh, CH; Kwon, SH; Na, JI; Park, KC; Shin, JW; Yang, JH	1
An, SM; Baek, JH; Jung, H; Kim, M; Kim, S; Kim, SJ; Koh, JS; Seo, R; Yang, H	1
Mazurek, K; Pierzchała, E	1
Huh, CH; Huh, SY; Na, JI; Park, KC; Shin, JW; Youn, SW	1
Duteil, L; Kaiafa, A; Khemis, A; Ortonne, JP; Queille-Roussel, C	1

Trials

4 trial(s) available for 4-n-butylresorcinol and Melanosis

Article	Year
Efficacy of liposome-encapsulated 4-n-butylresorcinol and resveratrol cream in the treatment of melasma. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:4 Topics: Adult; Cosmeceuticals; Drug Synergism; Female; Humans; Liposomes; Male; Melanins; Melanosis; Middle Aged; Photography; Resorcinols; Resveratrol; Severity of Illness Index; Skin; Skin Cream; Treatment Outcome	2020
4-n-butylresorcinol dissolving microneedle patch for skin depigmentation: a randomized, double-blind, placebo-controlled trial. Journal of cosmetic dermatology, 2016, Volume: 15, Issue:1 Topics: Adolescent; Adult; Animals; Dermatitis, Irritant; Double-Blind Method; Drug Delivery Systems; Female; Humans; Lentigo; Melanins; Melanosis; Middle Aged; Resorcinols; Skin Absorption; Skin Lightening Preparations; Skin Pigmentation; Swine; Young Adult	2016
Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial. The Journal of dermatology, 2010, Volume: 37, Issue:4 Topics: Adult; Asian People; Capsules; Dosage Forms; Female; Humans; Korea; Liposomes; Melanosis; Middle Aged; Monophenol Monooxygenase; Oxidoreductases; Patient Satisfaction; Resorcinols; Treatment Outcome	2010
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. The British journal of dermatology, 2007, Volume: 156, Issue:5 Topics: Administration, Topical; Adult; Dermatologic Agents; Double-Blind Method; Female; Humans; Italy; Melanosis; Middle Aged; Prospective Studies; Resorcinols; Skin Pigmentation; Treatment Outcome	2007

Other Studies

1 other study(ies) available for 4-n-butylresorcinol and Melanosis

Article	Year
Comparison of efficacy of products containing azelaic acid in melasma treatment. Journal of cosmetic dermatology, 2016, Volume: 15, Issue:3 Topics: Adult; Cosmeceuticals; Dermatologic Agents; Dicarboxylic Acids; Drug Combinations; Female; Humans; Mandelic Acids; Melanosis; Middle Aged; Phytic Acid; Resorcinols; Time Factors	2016